Trending

Monica Burt on Why Most MedTech Companies Are Doing Quality

Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing

Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing

Forécreu Acquires Grover Precision, Further Establishing Global Leadership in Cannulated

Certain Nano Surface Technology Assets Developed by Nanovis Have Been

April 24, 2025
Medtech Momentum, schedule a meeting
Subscribe
Notification
Latest News

Monica Burt on Why Most MedTech Companies Are Doing Quality All Wrong—and How to Fix It Before It Breaks You

Apr 18, 2025

Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing Director – Episode 1, Part 2

Apr 15, 2025

Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing Director – Episode 1, Part 1

Apr 10, 2025

Forécreu Acquires Grover Precision, Further Establishing Global Leadership in Cannulated Bar Technology

Mar 06, 2025
The MedTech Digest > MedTech Trends
18
Apr

Monica Burt on Why Most MedTech Companies Are Doing Quality All Wrong—and How to Fix It Before It Breaks You

  • Guillaume Viallaneix / 6 days
  • 5 min read

“We often joke that we’re the Green Berets of quality,” says Monica Burt, founder of MB&A. “When things go sideways—an FDA audit is imminent, a system is unraveling, or a product launch is on life support—we get the call.”In this candid conversation with The MedTech Digest, Monica Burt pulls back the curtain on why most MedTech companies are doing quality all wrong—and how her team is helping them fix it before it breaks them. From debunking the myth that more paperwork equals more compliance, to rebuilding systems that actually enable innovation, Burt’s insights are equal parts sharp, strategic, and human.

15
Apr

Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing Director – Episode 1, Part 2

  • Guillaume Viallaneix / 1 week
  • 6 min read

MedTech companies from both sides of the Atlantic kept reaching out to us since the beginning of the year, worried about what was happening in the U.S. with the new administration and how it might affect their business. They wanted guidance, insights, and most importantly, an educated path forward.

10
Apr

Tariff Talks: One-on-One with Tim Sheehan, BlackPoint Capital Markets, Managing Director – Episode 1, Part 1

  • Guillaume Viallaneix / 2 weeks
  • 10 min read

MedTech companies from both sides of the Atlantic kept reaching out to us since the beginning of the year, worried about what was happening in the U.S. with the new administration and how it might affect their business. They wanted guidance, insights, and most importantly, an educated path forward.

2025 US Tariffs in the MedTech Space
07
Feb

Tariff Time Bomb: European and American MedTech Companies Can Act Now to Turn a Potential Crisis into Opportunity

  • Guillaume Viallaneix / 3 months
  • 4 min read

In an era defined by geopolitical maneuvering and protectionist impulses, European MedTech companies now face a pivotal moment. The U.S. administration’s latest proposal to impose steep tariffs on multiple countries worldwide, including European imports, is not just a policy tweak; it is a signal of a return to a high-stakes trade environment reminiscent of history’s […]

Medtech marketing how to post
05
Feb

Turning PR into Results: Lessons from Unify Medical’s TIME Magazine Feature

  • Guillaume Viallaneix / 3 months
  • 3 min read

In today’s noisy digital landscape, standing out isn’t just about having groundbreaking technology; it’s about ensuring the right people know about it. Public Relations (PR) have emerged as a key driver in connecting innovation with opportunity This article describes how, upon landing a coveted spot in TIME Magazine’s Best Inventions of 2024 with it’s innovative […]

The Pricing Problem: Are Conferences Outpricing Their Audience?
08
Oct

The State of Healthcare Conferences in 2024: Rebooting for the Future

  • Guillaume Viallaneix / 7 months
  • 4 min read

Last week, I attended the North American Spine Society (NASS) conference in Chicago for the 24th year in a row. While the event retained its familiar warmth, I couldn’t ignore the challenges—lower attendance, fewer exhibitors, and a noticeable shift in energy compared to the pre-pandemic years. This isn’t just an issue unique to NASS; these […]

attract customers
08
Oct

The Lead Generation Problem No One Talks About in MedTech—and How to Solve It

  • Guillaume Viallaneix / 7 months
  • 4 min read

Let’s face it—if you’re in the MedTech industry, lead generation is likely one of your biggest challenges. It’s no longer just about gathering contact information. The stakes are much higher for Medical Technology companies: regulatory complexities, extended sales cycles, and an ever-evolving industry make it increasingly difficult to attract and convert the right leads. So, […]

Cody Simmons
22
May

Exclusive Interview: A Look Inside DermaSensor’s Journey to Innovation with CEO, Cody Simmons

  • Guillaume Viallaneix / 11 months
  • 16 min read

I’ve learned and shared with people that whenever you have a major setback – whether study-related, study timeline change or product setback and timeline change, just reevaluate your whole approach and strategy because even with your well-laid plans, when one of the pieces of the plan changes, you realize other doors could open.